TFF Pharmaceuticals To Present Data From Phase 2 Trial Of Voriconazole Inhalation Powder For Treatment Of Invasive Pulmonary Aspergillosis At 11th Advances Against Aspergillosis & Mucormycosis Conference
Author: Benzinga Newsdesk | January 24, 2024 09:17am